Latest News
CytoDyn Provides Update on Dose Escalating Trial with Leronlimab for HIV Monotherapy for a Potential Pivotal Trial
Onconova Therapeutics, Inc. Reports Business Highlights and Second Quarter 2019 Financial Results
Onconova Therapeutics, Inc. to Provide Corporate Update and Second Quarter 2019 Financial Results
Patient Treated with Leronlimab (PRO 140) for Metastatic Triple-
CytoDyn Sponsored Research Reaffirms the Role of CCR5 in Cancer Biology and Provides a New Potential Cancer Treatment Modality
Inner Spirit Holdings Announces Seven New Licences for Spiritleaf Retail Cannabis Stores in Alberta and 14 Spiritleaf Stores Anticipated to Open in the Province in August
Folium Biosciences Attends Cosmoprof for 2nd Year
CytoDyn Executes Exclusive Worldwide Licensing Agreement with IncellDX for PA-
CytoDyn Finalizes Development of Receptor Occupancy Test to Guide Pivotal Monotherapy Discussions With the FDA
Inner Spirit Holdings Announces Six New Licences for Spiritleaf Retail Cannabis Stores in Alberta And Opening of New Spiritleaf Corporate Store in Jasper
Helius Medical Technologies, Inc. Announces Results of Matters Submitted for Vote at 2019 Annual Meeting of Stockholders